Early vs. Late Tourniquet Release and Phlebotomy-Induced Hemolysis in the Emergency Department: The TOURNI-ED Randomized Trial
NCT07617103 · Status: NOT_YET_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 792
Last updated 2026-06-01
Summary
BACKGROUND:
Hemolysis is the most common preanalytical error in emergency department (ED) laboratories, affecting 17-26% of blood samples collected in the ED and leading to test cancellations, repeat venipuncture, delayed diagnoses, and increased healthcare costs. Venous stasis created by tourniquet application during phlebotomy is a recognized contributing factor to hemolysis. While clinical guidelines recommend releasing the tourniquet once blood flow is established, the optimal timing of tourniquet release in relation to tube filling sequence has not been systematically evaluated.
OBJECTIVE:
The primary objective of this trial is to determine whether early release of sphygmomanometer-applied venous stasis (released after the first tube fills) reduces hemolysis rates compared to late release (released after the last tube fills) during routine phlebotomy in ED patients triaged as green or yellow category.
DESIGN:
Single-center, parallel-group, superiority randomized controlled trial with 1:1 allocation ratio. The trial was prospectively registered prior to the enrollment of the first participant.
PARTICIPANTS:
Adult patients (≥18 years) presenting to the emergency department with triage category green (semi-urgent) or yellow (urgent), for whom blood collection is indicated as part of routine clinical care. Patients requiring blood collection from an intravenous catheter, those with known coagulation disorders, and those who decline to participate are excluded.
INTERVENTIONS:
Group A (Early Release): Sphygmomanometer inflated to 60 mmHg for venous stasis; tourniquet released immediately after the first tube (sodium citrate, blue cap) completes filling. Remaining tubes (SST/gel, yellow cap; K2-EDTA, purple cap) are collected after release.
Group B (Late Release): Sphygmomanometer inflated to 60 mmHg; tourniquet maintained throughout all tube filling and released only after the last tube (K2-EDTA, purple cap) completes filling. Tube collection order follows the CLSI H03-A6 standard for both groups.
PRIMARY OUTCOME:
Hemolysis rate, defined as the proportion of serum separator tube (SST/yellow cap) samples with a Hemolysis Index (HI) ≥ 1+ (corresponding to free hemoglobin ≥50 mg/dL), is assessed by the clinical chemistry laboratory analyzer. The outcome assessor (laboratory technician) is blinded to group assignment.
SECONDARY OUTCOMES:
(1) Distribution of ordinal hemolysis index categories (-, 1+, 2+, 3+, 4+, 5+) in SST samples; (2) Proportion of hemolyzed samples requiring repeat blood collection; (3) Total blood collection duration (seconds) from sphygmomanometer inflation to last tube filling completion; (4) Complication rate (hematoma, nerve injury, vasovagal reaction, arterial puncture, multiple puncture attempts).
SAMPLE SIZE:
A total of 792 participants (396 per group) are required based on an assumed hemolysis rate of 12% in the late release group and 6% in the early release group (50% relative risk reduction), α=0.05 (two-tailed), 80% power (Fleiss with pooled variance), plus 10% dropout buffer.
RANDOMIZATION:
Simple randomization using a computer-generated random number list (randomizer.org). The allocation sequence is maintained by a designated person not involved in enrollment or data collection. Allocation is revealed sequentially at the point of care.
STATISTICAL ANALYSIS:
Primary analysis: Chi-square test comparing hemolysis rates between groups (intention-to-treat population). Secondary analyses: Mann-Whitney U test for ordinal HI distribution; logistic regression for adjusted odds ratio. Bonferroni correction applied to multiple secondary comparisons (adjusted α = 0.017). Per-protocol analysis performed as a sensitivity analysis. Missing data handled using complete case analysis with sensitivity analysis.
Conditions
- Hemolysis
- Blood Specimen Collection
- Phlebotomy
- Venous Stasis
Interventions
- PROCEDURE
-
Sphygmomanometer-Applied Venous Stasis with Varied Release Timing During Phlebotomy
A standard aneroid sphygmomanometer is used in place of a conventional tourniquet rubber strap to apply venous stasis at a standardized pressure of 60 mmHg prior to venipuncture. Blood is collected in three tubes in the following order: (1) sodium citrate tube (blue cap, 2.7 mL), (2) serum separator tube/SST (yellow cap, 5 mL), (3) K2-EDTA tube (purple cap, 3 mL). The intervention variable is the timing of sphygmomanometer release: immediately after tube 1 (Group A, early release) versus after tube 3 (Group B, late release).
Sponsors & Collaborators
-
Marmara University Pendik Training and Research Hospital
lead OTHER
Study Design
- Allocation
- RANDOMIZED
- Purpose
- PREVENTION
- Masking
- SINGLE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2026-06-30
- Primary Completion
- 2027-06-30
- Completion
- 2027-08-31
Countries
- Turkey (Türkiye)
Study Locations
More Related Trials
-
Low-Titer O Positive Whole Blood Versus Component Therapy for Emergent Transfusion in Trauma Patients
NCT05081063 ·Status: COMPLETED ·Phase: PHASE3
-
Rotational Thromboelastometry Guided Blood Component Use in Children With Cirrhosis Undergoing Invasive Procedures: A Randomized Controlled Trial
NCT04460222 ·Status: COMPLETED ·Phase: NA
-
A Transparent Elasticized Adhesive Occlusive Compression Bandage for Use as an Arterial Tourniquet
NCT02592655 ·Status: COMPLETED ·Phase: NA
-
Comparison of Rapid Thrombelastography and Conventional Coagulation Testing for Haemostatic Resuscitation in Trauma
NCT01536496 ·Status: COMPLETED ·Phase: NA
-
Rotational Thromboelastometry Activated Transfusion In Trauma Trial
NCT03765866 ·Status: COMPLETED ·Phase: NA
-
Blood Loss After Early TXA in Hip Fractures.
NCT04488367 ·Status: UNKNOWN ·Phase: EARLY_PHASE1
-
The Incidence of Early Trauma Induced Coagulopathy and Hyperfibrinolysis in Severely Injured Trauma Patients in the Emergency Room: a Retrospective Cohort Study
NCT07186712 ·Status: COMPLETED
-
Albumin vs. Plasma for PEdiAtric pRiming Trial
NCT02738190 ·Status: COMPLETED ·Phase: PHASE4
-
RETIC Trial: Reversal of Trauma Induced Coagulopathy Using Coagulation Factor Concentrates or Fresh Frozen Plasma
NCT01545635 ·Status: TERMINATED ·Phase: PHASE3
-
Pre-hospital Administration of Fibrinogen in Trauma-Induced Coagulopathy
NCT06582420 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Prehospital Transfusion Strategy in Bleeding Patients
NCT04879485 ·Status: COMPLETED ·Phase: NA
-
Fibrinogen Early In Severe Trauma studY Junior
NCT03508141 ·Status: UNKNOWN ·Phase: PHASE2
-
Use of Viscoelastic Tests in the Treatment of Traumatic Induced Coagulopathy: a Pragmatic Randomized Clinical Trial.
NCT03380767 ·Status: WITHDRAWN ·Phase: NA
-
Early Use of Cryoprecipitate With Major Hemorrhage Protocol (MHP) Activation
NCT04704869 ·Status: COMPLETED ·Phase: PHASE3
-
Using Decision Aids to Reducing Decision Conflict in Angiography Patients for Choosing Hemostasis
NCT03995381 ·Status: UNKNOWN ·Phase: NA
-
Performance of Junctional Tourniquets in Normal Human Volunteers
NCT01965561 ·Status: COMPLETED ·Phase: PHASE4
-
Abdominal Aortic Junction Tourniquet (AAJT-S) for Non-compressible Torso Haemorrhage
NCT06622317 ·Status: RECRUITING
-
Microvesicle Production After Acute Trauma and Its Clinical Impact on Venothromboembolism
NCT01264458 ·Status: COMPLETED
-
Trauma Associated Bleeding: Effectiveness of an Early Coagulation Support Protocol
NCT03354559 ·Status: COMPLETED
-
Efficacy and Safety of HemoStyp as an Adjunct for Management of Secondary Hemostasis in the Operative Setting
NCT03654560 ·Status: COMPLETED ·Phase: NA
-
HEMOBLAST Pivotal Clinical Investigation
NCT02780869 ·Status: COMPLETED ·Phase: NA
-
Blood Characteristics and Abdominal Emergency Surgery
NCT06028854 ·Status: SUSPENDED
-
A Prospective Evaluation of Thromboelastography for Identifying Coagulopathy in Severely Injured Patients
NCT01228058 ·Status: COMPLETED
-
Effectiveness of the Use of the New Hemostatic Patch Hemopatch ® in Patients Undergoing Surgical Liver Resection
NCT02769754 ·Status: UNKNOWN ·Phase: PHASE3
-
Multinational Haemapheresis Vigilance Study
NCT01576237 ·Status: UNKNOWN